Gw Henssler & Associates LTD Regeneron Pharmaceuticals, Inc. Transaction History

Gw Henssler & Associates LTD

$1.64 Billion
Q4 2024

A detailed history of Gw Henssler & Associates LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 17,817 shares of REGN stock, worth $12.5 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

17,817

Previous 18,068 1.39%

Holding current value

$12.5 Million

Previous $19 Million 33.18%

% of portfolio

0.77%

Previous 1.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$701.85 - $1046.91 $176,164 - $262,774	-251 Reduced 1.39%	17,817 $12.7 Million
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $488,490 - $573,239	-477 Reduced 2.57%	18,068 $19 Million
Q2 2024 Aug 01, 2024	SELL	$883.2 - $1071.19 $801,945 - $972,640	-908 Reduced 4.67%	18,545 $19.5 Million
Q1 2024 May 07, 2024	SELL	$902.69 - $993.35 $449,539 - $494,688	-498 Reduced 2.5%	19,453 $18.7 Million
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $409,295 - $465,537	-528 Reduced 2.58%	19,951 $17.5 Million
Q3 2023 Oct 24, 2023	SELL	$692.45 - $844.37 $294,291 - $358,857	-425 Reduced 2.03%	20,479 $16.9 Million
Q2 2023 Aug 02, 2023	SELL	$700.03 - $830.35 $138,605 - $164,409	-198 Reduced 0.94%	20,904 $15 Million
Q1 2023 Apr 26, 2023	SELL	$680.49 - $826.97 $129,293 - $157,124	-190 Reduced 0.89%	21,102 $17.3 Million
Q4 2022 Feb 03, 2023	BUY	$705.89 - $766.39 $289,414 - $314,219	410 Added 1.96%	21,292 $15.4 Million
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $235,901 - $297,695	411 Added 2.01%	20,882 $14.4 Million
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $30,159 - $40,636	55 Added 0.27%	20,471 $12.1 Million
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $220,194 - $258,419	370 Added 1.85%	20,416 $14.3 Million
Q4 2021 Jan 28, 2022	BUY	$543.48 - $670.97 $72,826 - $89,909	134 Added 0.67%	20,046 $12.7 Million
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $34,441 - $40,857	60 Added 0.3%	19,912 $12.1 Million
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $231,672 - $273,684	490 Added 2.53%	19,852 $11.1 Million
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $394,462 - $484,060	883 Added 4.78%	19,362 $9.16 Million
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $860,461 - $1.09 Million	-1,799 Reduced 8.87%	18,479 $8.93 Million
Q3 2020 Oct 22, 2020	SELL	$544.75 - $658.21 $7.49 Million - $9.05 Million	-13,744 Reduced 40.4%	20,278 $11.4 Million
Q2 2020 Jul 21, 2020	SELL	$493.32 - $643.92 $1.44 Million - $1.88 Million	-2,916 Reduced 7.89%	34,022 $21.2 Million
Q1 2020 Apr 27, 2020	SELL	$336.18 - $494.43 $342,231 - $503,329	-1,018 Reduced 2.68%	36,938 $18 Million
Q4 2019 Feb 24, 2020	BUY	$274.13 - $376.51 $503,028 - $690,895	1,835 Added 5.08%	37,956 $14.3 Million
Q3 2019 Nov 18, 2019	BUY	$273.46 - $318.39 $2.29 Million - $2.67 Million	8,382 Added 30.22%	36,121 $10 Million
Q2 2019 Aug 05, 2019	BUY	$299.6 - $414.82 $8.31 Million - $11.5 Million	27,739 New	27,739 $8.68 Million

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Account

Gw Henssler & Associates LTD Regeneron Pharmaceuticals, Inc. Transaction History